Skip to main content
main-content

27.02.2019 | Original Article

Characterization of tissue-specific biomarkers with the expression of circRNAs in forensically relevant body fluids

Zeitschrift:
International Journal of Legal Medicine
Autoren:
Baonian Liu, Feng Song, Qinrui Yang, Yuxiang Zhou, Chengchen Shao, Yiwen Shen, Ziqin Zhao, Qiqun Tang, Yiping Hou, Jianhui Xie
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s00414-019-02027-y) contains supplementary material, which is available to authorized users.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abstract

Messenger RNA (mRNA) markers have been extensively investigated for the identification of forensically relevant body fluids and tissues based on their expression profiles among cell types. As products of the backsplicing of pre-mRNAs, circular RNAs (circRNAs) share exonic sequences with their linear counterparts. The inclusion of circRNAs in mRNA profiling is shown to facilitate the detection of biomarkers in the identification of body fluids. In this study, we identified the expression of circRNAs of 14 out of 45 biomarkers from five body fluid types using outward-facing primer sets and revealed the ratio of circular to total transcripts of biomarkers by RNase R treatment. Furthermore, our results of qPCR analysis show that the inclusion of circRNAs in the detection of biomarkers, including HBA and ALAS2 for blood; MMP7 and MMP10 for menstrual blood; HTN3 for saliva; SPINK5, SERPINB3, ESR1, and CYP2B7P1 for vaginal secretions; TGM4, KLK3, and PRM2 for semen; and SLC22A6 and MIOX for urine, does not impair the specificity of these biomarkers. Additionally, a high copy number of targets from linear transcripts could be employed to increase the detection sensitivity of TGM4 and KLK3 with a low expression level of circRNAs in urine samples. Altogether, these results will help with the development of robust multiplex assays for body fluid identification.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Zusatzmaterial
High Resolution (TIF 2668 kb)
414_2019_2027_MOESM1_ESM.tif
High Resolution (TIF 1050 kb)
414_2019_2027_MOESM2_ESM.tif
High Resolution (TIF 1358 kb)
414_2019_2027_MOESM3_ESM.tif
High Resolution (TIF 1572 kb)
414_2019_2027_MOESM4_ESM.tif
Table S1 (DOCX 15 kb)
414_2019_2027_MOESM5_ESM.docx
Table S2 (DOCX 17 kb)
414_2019_2027_MOESM6_ESM.docx
Table S3 (DOCX 17 kb)
414_2019_2027_MOESM7_ESM.docx
Table S4 (DOCX 24 kb)
414_2019_2027_MOESM8_ESM.docx
Table S5 (DOCX 17 kb)
414_2019_2027_MOESM9_ESM.docx
Literatur
Über diesen Artikel

Neu im Fachgebiet Rechtsmedizin

07.03.2019 | Mammakarzinom | CME | Ausgabe 2/2019

Update der S3-Leitlinie Mammakarzinom

Was gibt es Neues für Pathologen?

21.02.2019 | Schwerpunkt: Neuropathologie | Ausgabe 2/2019

Neuropathologie der Medulloblastome und anderer embryonaler Tumoren des ZNS

Präzisierung der Diagnostik durch Integration genetischer Marker

21.02.2019 | Schwerpunkt: Neuropathologie | Ausgabe 2/2019

Integrierte Diagnostik der diffusen astrozytären und oligodendroglialen Gliome

04.02.2019 | Schwerpunkt: Gynäkopathologie | Ausgabe 1/2019 Open Access

Fallstricke und Probleme bei der Differenzialdiagnose epithelialer Ovarialtumoren